Merck's (MRK) KEYTRUDA and KEYTRUDA QLEX plus Paclitaxel +/- Bevacizumab has been approved for certain adults with PD-L1+ platinum-resistant ovarian carcinoma as second or third line treatment
Merck's approval of KEYTRUDA and KEYTRUDA QLEX for treating platinum-resistant ovarian carcinoma represents a significant advance in their oncology portfolio.
Secretary of State Rubio will meet Israel PM Netanyahu 09:00EST/14:00GMT at Blair House. Netanyahu will meet US President Trump at 11:00EST/16:00GMT at the White House
Bank of America (BAC) Consumer Checkpoint says consumer spending showed solid resilience in January, with total card spending +2.6% Y/Y, strongest in nearly two years, despite weather‑related disruptions
Merck's (MRK) KEYTRUDA and KEYTRUDA QLEX plus Paclitaxel +/- Bevacizumab has been approved for certain adults with PD-L1+ platinum-resistant ovarian carcinoma as second or third line treatment
US President Trump is privately considering exiting the North American trade pact, Bloomberg reports
Dutch Court maintains its October decision regarding the suspension of Nexperia's former CEO, will appoint two investigators at Nexperia on short notice
Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.
This could enhance their competitive position in the pharmaceutical market, particularly within Europe, and may lead to positive sentiment among investors regarding MRK's growth trajectory in the biotech sector. Keep an eye on peer reactions as this move could spur further consolidation or strategic partnerships in the oncology space.
Related headlines
- Daily US Equity Opening News: ORCL gains on earnings and FY guidance beat; ADBE weighed by slight Q4 revenue miss; SMR downgraded1 day ago
- Burry adds to his positions in Zoetis (ZTS) and Lululemon (LULU); sold entire position in Flutter (FLUT)1 day ago
- Newsquawk US Market Wrap: Markets chop, and yields flatten after hot core CPI boosts Fed rate hike bets1 day ago
- Additional European Equity News - 11th September 20262 days ago
- European Equity pre-Market Summary - 11th September 2026: European bourses rebound, with focus on the US CPI2 days ago
- Newsquawk Daily European Equity Opening News - 11th September 20262 days ago
- Newsquawk Daily US Opening News - 11th September 20261 day ago
- European Movers: Alstom (ALO FP) +1.7%, Airbus (AIR FP) +1.6%, UniCredit (UCG IM) +1%, Commerzbank (CBK GY) +0.6%, SAP (SAP GY) -1.6%2 days ago
- Germany is developing a pharmaceutical pricing proposal for the Trump administration in an effort to avert potential US tariffs on German goods, reports Politico citing sources1 day ago
- TREASURY WRAP: T-NOTE FUTURES (Z6) SETTLE 8 TICKS LOWER AT 106-03+1 day ago
- US FX WRAP: Dollar sees two-way action, but initially firms on hotter-than-expected core M/M print1 day ago
- US President Trump reiterates USD 5k payment to all US adults will happen 1 day ago
- CRUDE WRAP: WTI (V6) SETTLES USD 2.43 LOWER AT 100.05/BBL; BRENT (X6) SETTLES USD 3.02 LOWER AT 104.61/BBL1 day ago
- Estee Lauder (EL) reportedly advances against Walmart (WMT) over knockoffs, according to Bloomberg Law1 day ago
- Saudi Crown Prince MBS has personally urged President Trump to launch military strikes against Houthi forces in Yemen amid their rapid advance along the Red Sea coast, reports to CBS citing sources1 day ago
- Trump removes 50% tariff on bulk Canadian whisky and liquers, effective September 15th1 day ago
- US President Trump reiterates that Iran will never possess a nuclear weapon1 day ago
- US EQUITY OPEN: US indices reverse initial CPI losses1 day ago
- Newsquawk European Market Wrap - 11th September 20261 day ago
- Newsquawk Weekly US Earnings Estimates: 14-18th September 2026: LEN the only earning all week1 day ago
The whole workspace, free to try.
Try it free